血糖モニタリング市場：製品、検査技術、用途、流通チャネル、エンドユーザー別-世界予測2024-2030年

血糖モニタリング市場規模は、2023年に130億6,000万米ドルと推定され、2024年には140億8,000万米ドルに達し、CAGR 8.28%で2030年には228億米ドルに達すると予測されています。

血糖モニタリングは、糖尿病を管理する個人にとって重要な、血液中のグルコースレベルを追跡する継続的なプロセスを指します。これは、糖尿病を管理する個人にとって極めて重要です。この実践は、食事、運動、薬物療法に関して十分な情報を得た上での意思決定に役立ち、血糖値の効果的な管理と糖尿病関連合併症のリスク低減に貢献します。糖尿病モニタリングの利用拡大は、世界の糖尿病有病率の増加、より簡便で侵襲性の低いモニタリングオプションを提供する技術の進歩、血糖コントロールの重要性に対する意識の高まり、統合ケアモデルの発展などが主な要因です。しかし、頻繁に指を刺す検査に関連する不快感や痛み、モニタリング用品のコスト、使用者のミスや機器の故障による不正確な測定値の可能性などが、製品採用に影響を与えています。メーカー各社は、ユーザーの関与を減らしながら、苦痛のないリアルタイムのモニタリングを提供する持続型グルコースモニター（CGM）の開発に注力しており、データの追跡と分析を強化するためにモバイル技術と統合できるスマートデバイスへの投資も行っています。非侵襲的技術、予測分析のための人工知能（AI）、よりパーソナライズされた効率的な糖尿病管理に貢献する相互接続されたヘルスケア機器など、血糖モニタリングにおける将来の機会は豊富です。

製品自己血糖モニターにおける個別化ガイダンスの提供します。

持続血糖モニターは、リアルタイムのグルコースモニタリングを必要とする患者、特に1型糖尿病患者や集中的なインスリン治療が必要な患者に最適です。CGMは、1日を通してグルコースレベルの動向を追跡し、より正確なインスリン投与と全体的なグルコース管理を可能にすることで恩恵を受けるユーザーに処方されます。自己血糖測定（SMBG）装置と比較して、CGMは、皮膚穿刺を繰り返す必要がなく、連続的で動的なグルコースレベルの測定値を提供するという利点があります。CGMは、高血糖と低血糖の発生率を低下させ、生活の質を高め、血糖コントロールを改善することができます。自己血糖測定装置は、継続的なモニタリングは必要ないが、定期的な血糖値のチェックが必要な人に使用されます。これらは1型糖尿病と2型糖尿病の両方の患者、特に食事療法、運動療法、経口薬物療法、または時折のインスリン注射によって病状を管理している患者に適しています。SMBG装置は、検査時のグルコース値のスナップショットを提供するため、より洗練されたCGMと比較して、より少ないコミットメントと費用を必要とします。しかし、SMBGは穿刺検査に依存しており、不快感や不便さのために一部のユーザーにとっては魅力的でない場合があります。

検査技術：携帯型および家庭用機器として開発される電極式血糖測定器の可能性

電極式血糖測定器は、電気化学反応を利用して血液中のグルコース濃度を測定します。少量の血液サンプルを、グルコースと反応する酵素を含むテストストリップの上に置く。この反応により小さな電流が発生し、電極で測定され、グルコース値がモニターに表示されます。光電式血糖測定器は光測定の原理を応用したもので、光線を利用して血液中のグルコース量を測定します。光はテストストリップ上の血液サンプルと相互作用し、吸収された光の量がグルコース濃度を示します。電極式モニターは、迅速かつ高精度の測定が可能であるため、医療・救急現場や綿密な管理を行う糖尿病患者に適しています。一方、光電式モニターは非侵襲的な代替手段を提供し、快適さと潜在的な反復コストの低減を求める人々に対応しています。

アプリケーション1型糖尿病に対する精度と常時監視を備えた高度なCGMの必要性

妊娠糖尿病（GDM）は、さまざまな重症度の耐糖能異常を特徴とし、一般的に妊娠中に発症します。GDMに対する血糖モニタリングは、母体と発育中の胎児の健康を確保するために極めて重要です。GDM患者には、一時的な状態であることを考慮し、グルコースレベルを効果的に管理するために、精度が高く、使いやすいモニタリングツールが必要です。1型糖尿病患者には、生涯にわたるインスリン療法と定期的な血糖モニタリングが必要です。1型糖尿病は、生涯にわたるインスリン療法と定期的なグルコース管理が必要であり、GDMは、リアルタイムの測定値とトレンド情報を提供する持続グルコースモニタリングシステム（CGM）が必要です。2型糖尿病は、生活習慣が関係していることが多く、定期的なチェックのために個人用血糖モニターが必要です。患者は、手頃な価格で使いやすい血糖測定器を好むかもしれないです。長期観察のためにデータを保存できる接続機能を備えた血糖モニターは、このセグメントにアピールします。妊娠糖尿病では、高度なデータ管理と共有機能を備えた一時的モニタリングソリューションが重視されます。対照的に、1型糖尿病モニタリング・ソリューションは、正確さと常時モニタリングを優先しています。一方、2型糖尿病市場は、患者が糖尿病管理と他の生活とのバランスを取る必要があることが多いため、コスト効率と使いやすさに重点を置いています。

エンドユーザー：病院における臨床効率と患者のスループットを最適化する血糖値モニターの提供します。

ホームケアは、主に非臨床環境で糖尿病患者または糖尿病発症リスクのある患者が使用する血糖モニタリングソリューションに関連します。ホームケア分野では、ユーザーは一般的にコンパクトで使いやすく、メンテナンスが最小限で済む機器を好みます。スマートフォンとの接続や、遠隔患者モニタリングのためのシームレスなデータ転送などの機能は、ますます人気が高まっています。正確さ、手頃な価格、低侵襲技術も、在宅医療ユーザーの嗜好リストの上位にあります。病院や診療所は、血糖モニタリングのもう一つの主要セグメントであり、精度、リアルタイムモニタリング、病院管理システムとの統合、入院患者の包括的ケアの促進が重視されています。このような施設では、大量の患者をサポートし、電子カルテ（EHR）統合のための堅牢な接続性を提供し、即時の臨床判断に役立つ正確で迅速な測定値を確保できる機器が求められます。二次汚染の問題を防ぐため、高品質で信頼性が高く、滅菌が容易な機器が好まれます。

地域別インサイト

南北アメリカでは、特に糖尿病治療市場が成熟している米国での糖尿病有病率の増加により、血糖モニタリング機器が広く使用されています。この地域におけるシステムの生産は、高度な技術革新、厳格な規制監督、研究開発への多額の投資が特徴です。南北アメリカを拠点とする主要企業は、持続グルコースモニタリング（CGM）装置やフラッシュグルコースモニタリングシステムなど、高度なモニタリングシステムを提供しています。一方、アジア太平洋（APAC）地域では、特に中国やインドなどの新興経済圏において、糖尿病人口の増加、ヘルスケア意識の高まり、ヘルスケアインフラの改善によって、血糖モニタリング市場が急成長しています。APACにおける生産は、費用対効果とアクセシビリティを重視する傾向にあり、国際的企業は急増する需要を取り込もうと足場を広げています。西欧では、南北アメリカと同様に革新的で非侵襲的なモニタリング技術に対する強い需要が見られる一方、中東とアフリカは新興市場であり、コストの制約や医療インフラのレベルの違いから、基本的なグルコースモニタリングシステムに重点が置かれています。EMEA地域の企業は、先進的な製品を導入することと、地域のさまざまな地域における手頃な価格に対応することのバランスをとる努力をしています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは血糖モニタリング市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、血糖モニタリング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.血糖モニタリング市場の市場規模および予測は？

2.血糖モニタリング市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.血糖モニタリング市場の技術動向と規制枠組みは？

4.血糖モニタリング市場における主要ベンダーの市場シェアは？

5.血糖モニタリング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病の蔓延と啓発プログラムの改善
    • 非侵襲的血糖モニタリング技術への好感度の高まり
    • 継続的な在宅ケアの必要性
  • 抑制要因
    • 血糖モニタリングシステムの悪影響の想起
  • 機会
    • 血糖モニタリングシステムの設計と機能の進歩
    • 血糖モニタリングの払い戻しの強化
  • 課題
    • 血糖モニタリングの制作と運用の複雑さ
• 市場セグメンテーション分析
  • 製品：自己血糖測定器における個別ガイダンスの提供
  • 試験技術：携帯型・家庭用機器として開発される電極式血糖値モニターの可能性
  • 用途：1型糖尿病の正確性と継続的なモニタリングを備えた高度なCGMの必要性
  • エンドユーザー：病院における臨床効率と患者スループットを最適化する血糖値モニターの提供
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 血糖モニタリング市場：製品別

• 持続血糖モニター
• セルフまたはワンタイムモニター

第7章 血糖モニタリング市場テスト技術

• 電極式血糖値モニター
• 光電式血糖値モニター

第8章 血糖モニタリング市場：用途別

• 妊娠糖尿病
• 1型糖尿病
• 2型糖尿病

第9章 血糖モニタリング市場：流通チャネル別

• オフライン
• オンライン

第10章 血糖モニタリング市場：エンドユーザー別

• ホームケア
• 病院・クリニック

第11章 南北アメリカの血糖モニタリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の血糖モニタリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの血糖モニタリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • アボット、ビッグフット・バイオメディカルの買収を完了
  • デクスコム、インスリンなしで2型糖尿病を管理できる新しいウェアラブルを発表
  • アステラス製薬とロシュ・ダイアベティス・ケア・ジャパン、ブルースターと提携し統合糖尿病自己管理ソリューションの開発・商品化に向け提携契約を締結
• 戦略分析と提言

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
• FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 63. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 79. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 80. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 81. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 82. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 83. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 84. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 87. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 88. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 89. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 90. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 91. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 92. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 93. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 96. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 97. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 98. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 99. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 100. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 101. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 102. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 103. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 104. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 105. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 106. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 107. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 108. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 109. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 110. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 111. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 114. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 115. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 116. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 117. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 118. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 119. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 120. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 121. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 122. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 123. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 124. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 125. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 126. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 127. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 128. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 129. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 130. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 131. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 132. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 133. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 134. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 135. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 138. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 139. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 140. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 141. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 142. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 144. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 146. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 147. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 148. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 149. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 150. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 151. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 154. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 155. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 156. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 157. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 158. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 159. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 160. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 161. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 162. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 163. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 164. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 165. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 166. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 167. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 170. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 171. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 172. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 173. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 174. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 175. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 176. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 177. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 178. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 179. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 180. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 181. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 184. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 185. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 188. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 189. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 190. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 191. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 192. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 193. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 194. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 195. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 196. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 197. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 198. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 199. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 200. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 201. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 202. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 203. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 204. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 205. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 206. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 207. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 208. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 209. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 212. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 213. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 214. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 215. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 216. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 217. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 218. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 219. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 220. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 221. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 222. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 223. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 224. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 225. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 226. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 227. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 228. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 229. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 230. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 231. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 232. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 233. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 234. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 235. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 236. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 237. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 238. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 239. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 240. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 241. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 242. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 243. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 244. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 245. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 246. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 247. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 248. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 249. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 250. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 251. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 254. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 255. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 256. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 257. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 258. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 259. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 260. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 261. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 262. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 263. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 264. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 265. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 266. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 267. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 268. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 269. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 272. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 273. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 274. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 275. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 276. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 277. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 278. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 279. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 280. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 281. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 282. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 283. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 284. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 285. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 286. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 287. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 288. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 289. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 290. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 291. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 292. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 293. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 294. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 295. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 296. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 297. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 298. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 299. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 300. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 301. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
• TABLE 302. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
• TABLE 303. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
• TABLE 304. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
• TABLE 305. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 306. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 307. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 308. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 309. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
• TABLE 310. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
• TABLE 311. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 312. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 313. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 314. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)

[194 Pages Report] The Blood Glucose Monitoring Market size was estimated at USD 13.06 billion in 2023 and expected to reach USD 14.08 billion in 2024, at a CAGR 8.28% to reach USD 22.80 billion by 2030.

Blood glucose monitoring refers to the ongoing process of tracking the levels of glucose in the bloodstream, which is crucial for individuals managing diabetes. This practice helps in making informed decisions regarding diet, exercise, and medication, contributing to the effective management of blood sugar levels and reducing the risk of diabetes-related complications. The expansion of its use is primarily driven by the growing prevalence of diabetes globally, advancements in technology that provide more convenient and less invasive monitoring options, increased awareness about the importance of glycemic control, and the development of integrated care models. However, discomfort and pain related to frequent finger-prick tests, the cost of monitoring supplies, and the potential for inaccurate readings due to user error or device malfunction impact the product adoption. Manufacturers are focusing on developing continuous glucose monitors (CGMs) that offer painless, real-time monitoring while reducing user involvement, as well as investing in smart devices that can integrate with mobile technology for enhanced data tracking and analysis. The future opportunities in blood glucose monitoring are abundant, with prospects of non-invasive techniques, artificial intelligence (AI) for predictive analytics, and interconnected healthcare devices that could contribute to a more personalized and efficient diabetes management landscape.

Product: Provision of personalized guidance in self-monitoring blood glucose monitors

Continuous blood glucose monitors are ideal for patients who require real-time glucose monitoring, particularly those with Type 1 diabetes or those who have intensive insulin therapy needs. CGMs are prescribed for users who benefit from tracking trends in glucose levels throughout the day, enabling more precise insulin dosing and better overall glucose management. Compared to self-monitoring blood glucose (SMBG) devices, CGMs offer the advantage of providing continuous, dynamic glucose level readings without the need for repeated skin punctures. They can reduce the incidence of both hyperglycemia and hypoglycemia, enhance quality of life, and improve glycemic control. Self-monitoring blood glucose devices are used by individuals who may not need continuous monitoring but still require regular checks of their glucose levels. These are suited for patients with both Type 1 and Type 2 diabetes, particularly those who manage their condition through diet, exercise, oral medication, or occasional insulin injections. SMBG devices provide a snapshot of the glucose level at the time of testing, requiring less commitment and expense compared to the more sophisticated CGMs. However, SMBGs rely on puncture tests, which can be less appealing to some users due to discomfort or inconvenience.

Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices

Electrode-type blood glucose monitors function by utilizing electrochemical reactions to measure glucose levels in the blood. A small blood sample is placed on a test strip, which contains an enzyme that reacts with glucose. The reaction produces a small electrical current that is measured by the electrodes, and the glucose level is then displayed on the monitor. Photoelectric blood glucose monitors work on the principle of photometry and uses a beam of light to measure the amount of glucose in the blood. The light interacts with the blood sample on the test strip, and the amount of light absorbed indicates the glucose concentration. Electrode-type monitors offer quick and highly accurate measurements, which makes them suitable for medical and emergency settings, as well as for diabetic patients who closely manage their condition. On the other hand, photoelectric monitors provide a non-invasive alternative that caters to those who seek comfort and potentially lower repetitive costs.

Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes

Gestational diabetes mellitus (GDM) is characterized by glucose intolerance of varying severity and typically occurs during pregnancy. Blood glucose monitoring for GDM is critical to ensure the health of the mother and the developing fetus. Patients with GDM may have a specific need for monitoring tools with high accuracy and ease of use to manage glucose levels effectively, considering the temporary phase of their condition. Individuals with Type 1 Diabetes require lifelong insulin therapy and regular blood glucose monitoring. GDM requires continuous glucose monitoring systems (CGMs) that provide real-time readings and trend information, which can help in the tight management of their condition. Type 2 Diabetes, often related to lifestyle factors, requires personal blood glucose monitors for regular checks. Patients might prefer affordable and simple-to-use glucometers. Blood glucose monitors with connectivity features that can store data for long-term observation appeal to this segment. For gestational diabetes, the market emphasizes temporary monitoring solutions with advanced data management and sharing capabilities. In contrast, Type 1 Diabetes monitoring solutions prioritize accuracy and constant monitoring. Meanwhile, the market for Type 2 Diabetes focuses on cost-efficiency and ease of use, as patients often need to balance diabetes management with other life commitments.

End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals

Home care pertains to blood glucose monitoring solutions used by individuals with diabetes or at risk of developing diabetes, primarily in a non-clinical setting. In the home care segment, users typically prefer compact, easy-to-use devices with minimal maintenance. Features such as connectivity to smartphones and seamless data transfer for remote patient monitoring are increasingly popular. Accuracy, affordability, and minimally invasive technology are also high on the preference list for home care users. Hospitals and clinics represent another major segment for blood glucose monitoring, where the emphasis is on precision, real-time monitoring, integration with hospital management systems, and the facilitation of comprehensive care for inpatients. These establishments require devices that can support a high volume of patients, offer robust connectivity for electronic health records (EHR) integration, and ensure precise, quick readings to inform immediate clinical decisions. High-quality, reliable, and easily sterilizable devices are preferred to prevent cross-contamination issues.

Regional Insights

In the Americas, blood glucose monitoring devices are widely used, owing to the increasing prevalence of diabetes, particularly in the United States, which has a mature market for diabetes care. The production of these systems in this region is characterized by high technological innovation, stringent regulatory oversight, and substantial investments in research and development. Major companies based in the Americas provide advanced monitoring systems, including continuous glucose monitoring (CGM) devices and flash glucose monitoring systems. On the other hand, in the Asia-Pacific (APAC) region, there is rapid growth in the blood glucose monitoring market, fueled by the rising diabetic population, growing healthcare awareness, and improving healthcare infrastructure, particularly in emerging economies such as China and India. Production in APAC tends to focus on cost-effectiveness and accessibility, with international companies expanding their footprint to capture the burgeoning demand. Western Europe shows a strong demand for innovative and non-invasive monitoring technologies similar to the Americas, while the Middle East and Africa are emerging markets with a focus on basic glucose monitoring systems due to cost constraints and varying levels of healthcare infrastructure. Companies in the EMEA region are working to strive to balance between introducing advanced products and catering to affordability in different parts of the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Glucose Monitoring Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Glucose Monitoring Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Continuous Blood Glucose Monitors
    • Insulin Pumps
    • Sensors
    • Transmitter & Receiver

• Self or One Time Monitors
  • Blood Glucose Meter
  • Lancets
  • Testing Strips
• Testing Technology
  • Electrode Type Blood Glucose Monitor
  • Photoelectric Blood Glucose Monitor

• Application
  • Gestational Diabetes
  • Type 1 Diabetes
  • Type 2 Diabetes

• Distribution Channel
  • Offline
  • Online

• End-User
  • Home Care
  • Hospital & Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Glucose Monitoring Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Glucose Monitoring Market?

3. What are the technology trends and regulatory frameworks in the Blood Glucose Monitoring Market?

4. What is the market share of the leading vendors in the Blood Glucose Monitoring Market?

5. Which modes and strategic moves are suitable for entering the Blood Glucose Monitoring Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of diabetes and improved awareness programs
    • 5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
    • 5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse recalls of blood glucose monitoring systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
    • 5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity in the production and operation of blood glucose monitoring
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
  • 5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
  • 5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
  • 5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Blood Glucose Monitoring Market, by Product

• 6.1. Introduction
• 6.2. Continuous Blood Glucose Monitors
• 6.3. Self or One Time Monitors

7. Blood Glucose Monitoring Market, by Testing Technology

• 7.1. Introduction
• 7.2. Electrode Type Blood Glucose Monitor
• 7.3. Photoelectric Blood Glucose Monitor

8. Blood Glucose Monitoring Market, by Application

• 8.1. Introduction
• 8.2. Gestational Diabetes
• 8.3. Type 1 Diabetes
• 8.4. Type 2 Diabetes

9. Blood Glucose Monitoring Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Offline
• 9.3. Online

10. Blood Glucose Monitoring Market, by End-User

• 10.1. Introduction
• 10.2. Home Care
• 10.3. Hospital & Clinics

11. Americas Blood Glucose Monitoring Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Blood Glucose Monitoring Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Monitoring Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
  • 14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
  • 14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
• 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio